Foreign investors are pulling out of Indian bonds and equities at a record pace, as the Iran war-driven surge in oil prices fanned worries over a pick-up in inflation and clouded India’s growth outlook, sending the rupee reeling.Read More
Indian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and Torrent Pharma are identified as potential market leaders. Despite initial stockouts online, companies are adjusting supply. The market for these diabetes and obesity drugs is expected to grow significantly in India.Read More
Airline stocks fell sharply on Friday as IndiGo and SpiceJet slipped up to 5%. The government, meanwhile, reinstated a windfall tax of Rs 29.5 per litre on ATF exports. The move comes amid rising oil prices and geopolitical tensions, adding pressure on carriers already facing higher fuel costs and regulatory challenges.Read More
Middle East tensions are creating global market uncertainty. BlackRock’s Ben Powell notes significant drone and missile strikes in the UAE. The Strait of Hormuz remains a critical chokepoint. Investors are reducing risk exposure. US bond yields are rising, impacting global capital. Inflation remains a concern, with the Fed likely to maintain a hawkish stance.Read More
The Indian rupee is experiencing a significant decline. Global economic shifts and domestic challenges are driving this depreciation. Analysts point to a stronger US dollar and rising US bond yields. Elevated crude oil prices also pose a risk. This situation complicates the Reserve Bank of India’s policy outlook. The rupee may remain under pressure in the coming period.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
